More than 30 years ago, when University of California, Berkeley researchers discovered telomerase—an enzyme that lengthens chromosome ends and prevents them from fraying enough to kill a cell—speculation ran wild about its role in aging and cancer, setting off a full-court press to produce drugs to activate or block the enzyme.